Evidence map›Paper›PMID 40671524›Full record

ArticleNucleic acids research2025

Antitoxin control of optimal transcriptional repression in the atypical HigB-HigA toxin-antitoxin system from Proteus vulgaris.

Ian J Pavelich, Marc A Schureck, Pooja Srinivas, Taylor M Blackburn, Dongxue Wang, Eric D Hoffer, Michelle Boamah, Kimberly Zaldana, Nina Onuoha, Stacey J Miles and 3 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ian J PavelichDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Marc A SchureckDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Pooja SrinivasDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Taylor M BlackburnDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Dongxue WangDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Eric D HofferDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Michelle BoamahDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Kimberly ZaldanaDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Nina OnuohaDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Stacey J MilesDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.
Marcin GrabowiczDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, United States.
C Denise OkaforDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802, United States.ORCID 0000-0001-7374-1561
Christine M DunhamDepartment of Chemistry and the Emory Antibiotic Resistance Center, Emory University, Atlanta, GA 30322, United States.ORCID 0000-0002-8821-688X

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI Nozomi Ando, J Christopher Fromme · 2018 to 2026
$34.2M
Structural Studies of Ribosome RegulationR01GM093278 · NIGMS · EMORY UNIVERSITY · PI DUNHAM, CHRISTINE M · 2010 to 2022
$4.6M
Training Program in Biochemistry, Cell and Molecular BiologyT32GM135060 · NIGMS · EMORY UNIVERSITY · PI Lawrence H. Boise, ANITA H. CORBETT · 2020 to 2026
$2.8M
Antimicrobial Resistance and Therapeutic Discovery Training ProgramT32AI106699 · NIAID · EMORY UNIVERSITY · PI Graeme L Conn, Joanna B Goldberg · 2014 to 2026
$2.7M
Pixel Array Detector for Macromolecular CrystallographyS10OD021527 · OD · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2016 to 2016
$2.0M
Ribosome regulation, inhibition, and quality control mechanismsR35GM156629 · NIGMS · EMORY UNIVERSITY · PI Christine M Dunham · 2025 to 2026
$899k
Argonne National Laboratory DE-AC02-06CH11357Burroughs Wellcome Fund InvestigatorNIAID NIH HHS T32 AI106699NIGMS NIH HHS R01 GM093278NIGMS NIH HHS R35 GM156629NIGMS NIH HHS T32 GM135060NIH HHS 5T32 GM8367NIH HHS GM108351NIH HHS NRSA F31NIH HHS P30 GM124165NIH HHS R01GM093278NIH HHS R35 GM156629NIH HHS T32 AI106699NIH-ORIP HEI S10OD021527
6 · The paper itself

Abstract

Bacterial toxin-antitoxin (TA) pairs transcriptionally autoregulate their expression via a repression/derepression mechanism in response to changing environmental conditions. The structural diversity of TA systems influences the mechanisms of transcriptional regulation. Here, we define the molecular mechanism for the plasmid-encoded HigB-HigA TA pair originally identified in a post-operative infection with antibiotic-resistant Proteus vulgaris. We determine DNA binding and promoter activity by the HigB-HigA complex supported by structural biology and molecular dynamics simulations of an elusive DNA operator-TA repressor complex. To define the optimal oligomeric TA repressor-DNA operator complex required for derepression, we engineered a dedicated trimeric HigB-HigA2 complex that represses transcription more than 26-fold as compared to the tetrameric HigB2-HigA2. These results expand the known diversity of how the HigB-HigA TA family is autoregulated.

Indexed as

AntitoxinsBacterial ProteinsBacterial ToxinsGene Expression Regulation, BacterialProteus vulgarisToxin-Antitoxin SystemsTranscription, GeneticDNA, BacterialMolecular Dynamics SimulationOperator Regions, GeneticPlasmidsPromoter Regions, GeneticAntitoxinsBacterial ProteinsBacterial ToxinsDNA, Bacterial

Identifiers

PMID40671524
PMCPMC12266136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.